Integrated lipidomics in the secreted phospholipase A 2 biology

International Journal of Molecular Sciences

Volumn 12, Issue 3, 2011, Pages 1474-1495

  Murakami, Makoto ^a   Sato, Hiroyasu ^a   Taketomi, Yoshitaka ^a   Yamamoto, Kei ^a  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

Author keywords

Knockout mouse; Lipidomics; Phospholipase A 2; Phospholipid; Transgenic mouse

Indexed keywords

ESTERASE; PHOSPHOLIPASE A2; PHOSPHOLIPASE A2 GROUP IB; PHOSPHOLIPASE A2 GROUP II; PHOSPHOLIPASE A2 GROUP IIA; PHOSPHOLIPASE A2 GROUP III; PHOSPHOLIPASE A2 GROUP V; PHOSPHOLIPASE A2 GROUP X; PHOSPHOLIPASE A2 GROUP XII; UNCLASSIFIED DRUG; ISOPROTEIN; SECRETORY PHOSPHOLIPASE A2;

ADULT RESPIRATORY DISTRESS SYNDROME; ENZYME LOCALIZATION; ENZYME RELEASE; ENZYME STRUCTURE; ENZYME SUBSTRATE; HUMAN; LIPID HYDROLYSIS; LIPIDOMICS; MASS SPECTROMETRY; NONHUMAN; PATHOPHYSIOLOGY; PHOSPHOLIPID METABOLISM; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; ALOPECIA; ANIMAL; ATHEROSCLEROSIS; CELL MEMBRANE; DEFICIENCY; EPIDIDYMIS; GENETICS; GENITAL DISEASES, MALE; LUNG; MALE; METABOLISM; PATHOLOGY;

MAMMALIA; MUS; MUS MUSCULUS;

ALOPECIA; ANIMALS; ATHEROSCLEROSIS; CELL MEMBRANE; EPIDIDYMIS; GENITAL DISEASES, MALE; LUNG; MALE; PHOSPHOLIPASES A2, SECRETORY; PROTEIN ISOFORMS;

EID: 79953313874     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms12031474     Document Type: Review

References (100)

1. 2 in allergic response and parturition. Nature 1997, 390, 618-622.
2. 2 enzymes. Prostag. Other Lipid Mediat. 2002, 68-69, 3-58.
3. Lambeau, G.; Gelb, M.H. Biochemistry and physiology of mammalian secreted phospholipases A2. Annu. Rev. Biochem. 2008, 77, 495-520.
4. 2 enzymes: Lessons from transgenic and knockout mice. Biochimie 2010, 92, 561-582.
5. 2. J. Biol. Chem. 1994, 269, 2365-2368.
6. 2 attenuates cell migration and airway hyperresponsiveness in immunosensitized mice. J. Immunol. 2007, 179, 4800-4807.
7. 2 enzymes in lungs of humans with pneumonia and their potential prostaglandin-synthetic function in human lung-derived cells. Biochem. J. 2005, 387, 27-38.
8. 2 in mice leads to neonatal lethality because of lung dysfunction. J. Biol. Chem. 2006, 281, 36420-36433.
9. 2 in ARDS pathogenesis. Mol. Med. Today 1999, 5, 244-249.
10. Nag, K.; Munro, J.G.; Inchley, K.; Schürch, S.; Petersen, N.O.; Possmayer, F. SP-B refining of pulmonary surfactant phospholipid films. Am. J. Physiol. 1999, 277, L1179-L1189.
11. 2 protein interaction. J. Clin. Invest 1998, 102, 1152-1160
12. 2 in an animal model of acute lung injury. Am. J. Physiol. Lung. Cell Mol. Physiol. 2002, 282, L743-L750.
13. 2 synthesis via nuclear factor-κB. Am. J. Respir. Crit. Care Med. 2003, 168, 692-699.
14. Wang, Z.; Schwan, A.L.; Lairson, L.L.; O'Donnell, J.S.; Byrne, G.F.; Foye, A.; Holm, B.A.; Notter, R.H. Surface activity of a synthetic lung surfactant containing a phospholipase-resistant phosphonolipid analog of dipalmitoyl phosphatidylcholine. Am. J. Physiol. Lung Cell Mol. Physiol. 2003, 285, L550-L559.
15. 2 in oleic acid-induced acute lung injury in rabbits. Crit. Care Med. 2001, 29, 719-727.
16. 2. J. Immunol. 2003, 171, 995-1000.
17. 2 in human lung airway epithelial cells. Am. J. Respir. Cell Mol. Biol. 2000, 23, 37-44.
18. 2 -mediated surfactant dysfunction. Am. J. Physiol. Lung Cell Mol. Physiol. 2005, 288, L618-L624.
19. Shulenin, S.; Nogee, L.M.; Annilo, T.; Wert, S.E.; Whitsett, J.A.; Dean, M. ABCA3 gene mutations in newborns with fatal surfactant deficiency. N. Engl. J. Med. 2004, 350, 1296-1303.
20. Bridges, J.P.; Ikegami, M.; Brilli, L.L.; Chen, X.; Mason, R.J.; Shannon, J.M. LPCAT1 regulates surfactant phospholipid synthesis and is required for transitioning to air breathing in mice. J. Clin. Invest. 2010, 120, 1736-1748.
21. 2 regulates acute lung injury and neutrophilic inflammation caused by LPS in mice. Am. J. Physiol. Lung Cell Mol. Physiol. 2009, 296, L879-L887.
22. 2 reveals its role in house dust mite-induced allergic pulmonary inflammation by regulation of dendritic cell function. J. Immunol. 2010, 185, 4430-4438.
23. 2 in zymosan-induced eicosanoid generation and vascular permeability revealed by targeted gene disruption. J. Biol. Chem. 2004, 279, 16488-16494.
24. 2 translocates to the phagosome after zymosan stimulation of mouse peritoneal macrophages and regulates phagocytosis. J. Biol. Chem. 2006, 281, 6691-6698.
25. 2 modulates phagosome maturation and regulates the innate immune response against Candida albicans. J. Immunol. 2009, 182, 4891-4898.
26. 2 in immune complex-mediated arthritis. EMBO Mol. Med. 2010, 2, 172-187.
27. 2 promotes atherosclerosis: Evidence from genetically altered mice. Arterioscler. Thromb. Vasc. Biol. 2007, 27, 600-606.
28. 2 -IIA: Results from the UDACS study. Hum. Mol. Genet. 2007, 16, 1437-1444.
29. 2. J. Biol. Chem. 1997, 272, 15745-15752.
30. 2 in fibroblastic and mastocytoma cells through heparan sulfate shuttling and external plasma membrane mechanisms. J. Biol. Chem. 2001, 276, 10083-10096.
31. 2 but not the group IB, IIA, and V enzymes efficiently release arachidonic acid from adherent mammalian cells. J. Biol. Chem. 2000, 275, 3179-3191.
32. 2 is released during sperm acrosome reaction and controls fertility outcome in mice. J. Clin. Invest 2010, 120, 1415-1428.
33. 2 in reproduction, gastrointestinal phospholipid digestion, and neuronal function. J. Biol. Chem. 2011, in press.
34. 2 in allergen-induced airway inflammation and remodeling in a mouse asthma model. J. Exp. Med. 2007, 204, 865-877.
35. 2 group X overexpression in asthma and bronchial hyperresponsiveness. Am. J. Respir. Crit. Care Med. 2007, 176, 1072-1078.
36. 2 -deficient mice. Circulation 2008, 117, 2977-2985.
37. 2 group X enhances anti-inflammatory responses, promotes lipid accumulation, and contributes to aberrant lung pathology. J. Biol. Chem. 2008, 283, 21640-21648.
38. 2 in mouse skin. J. Biol. Chem. 2011, in press.
39. 2 in transgenic mice results in epidermal hyperplasia in the absence of inflammatory infiltrate. J. Clin. Invest 1996, 97, 2233-2241.
40. 2 in skin results in abnormal epidermis and increased sensitivity to chemical carcinogenesis. Oncogene 2003, 22, 1936-1944.
41. 2 is linked to macrophage foam cell formation. J. Biol. Chem. 2002, 277, 29116-29124.
42. 2 augments angiotensin II-induced inflammatory responses and abdominal aortic aneurysm formation in apoE-deficient mice. Atherosclerosis 2010, in press.
43. 2 negatively regulates ABCA1 and ABCG1 expression and cholesterol efflux in macrophages. Arterioscler Thromb. Vasc. Biol. 2010, 30, 2014-2021.
44. 2 regulates the expression of steroidogenic acute regulatory protein (StAR) in mouse adrenal glands. J. Biol. Chem. 2010, 285, 20031-20039.
45. 2 negatively regulates adipogenesis in murine models. FASEB J. 2010, 24, 4313-4324.
46. 2 with homology to the group III bee venom enzyme. J. Biol. Chem. 2000, 275, 7492-7496.
47. 2 s (groups III and XII). J. Biol. Chem. 2003, 278, 10657-10667.
48. 2. J. Biol. Chem. 2005, 280, 24987-24998.
49. 2 promotes neuronal outgrowth and survival. Biochem. J. 2008, 409, 429-438.
50. 2 -III as a biomarker candidate. Br. J. Cancer 2008, 98, 587-595.
51. 2 transgenic mice spontaneously develop inflammation. Biochem. J. 2009, 421, 17-27.
52. Emoto, K.; Inadome, H.; Kanaho, Y.; Narumiya, S.; Umeda, M. Local change in phospholipid composition at the cleavage furrow is essential for completion of cytokinesis. J. Biol. Chem. 2005, 280, 37901-37907.
53. Miyanishi, M.; Tada, K.; Koike, M.; Uchiyama, Y.; Kitamura, T.; Nagata, S. Identification of Tim4 as a phosphatidylserine receptor. Nature 2007, 450, 435-439.
54. 2. J. Biol. Chem. 2010, 285, 10993-11002.
55. 2 transgenic mice reveal potential participation of this enzyme in plasma lipoprotein modification, macrophage foam cell formation, and atherosclerosis. J. Biol. Chem. 2008, 283, 33483-33497.
56. Kimura-Matsumoto, M.; Ishikawa, Y.; Komiyama, K.; Tsuruta, T.; Murakami, M.; Masuda, S.; Akasaka, Y.; Ito, K.; Ishiguro, S.; Morita, H.; Sato, S.; Ishii, T. Expression of secretory phospholipase A2s in human atherosclerosis development. Atherosclerosis 2008, 196, 81-91.
57. Sato, H.; Taketomi, Y.; Isogai, Y.; Miki, Y.; Yamamoto, K.; Masuda, S.; Hosono, T.; Arata, S.; Ishikawa, Y.; Ishii, T.; Kobayashi, T.; Nakanishi, H.; Ikeda, K.; Taguchi, R.; Hara, S.; Kudo, I.; Murakami, M. Group III secreted phospholipase A2 regulates epididymal sperm maturation and fertility in mice. J. Clin. Invest 2010, 120, 1400-1414.
58. Cooper, T.G. Role of the epididymis in mediating changes in the male gamete during maturation. Adv. Exp. Med. Biol. 1995, 377, 87-101.
59. Rejraji, H.; Sion, B.; Prensier, G.; Carreras, M.; Motta, C.; Frenoux, J.M.; Vericel, E.; Grizard, G.; Vernet, P.; Drevet, J.R. Lipid remodeling of murine epididymosomes and spermatozoa during epididymal maturation. Biol. Reprod. 2006, 74, 1104-1113.
60. Lenzi, A.; Picardo, M.; Gandini, L.; Dondero, F. Lipids of the sperm plasma membrane: from polyunsaturated fatty acids considered as markers of sperm function to possible scavenger therapy. Hum. Reprod. 1996, 2, 246-256.
61. Lenzi, A.; Gandini, L.; Maresca, V.; Rago, R.; Sgrò, P.; Dondero, F.; Picardo, M. Fatty acid composition of spermatozoa and immature germ cells. Mol. Hum. Reprod. 2000, 6, 226-231.
62. Furimsky, A.; Vuong, N.; Xu, H.; Kumarathasan, P.; Xu, M.; Weerachatyanukul, W.; Bou, K.M.; Kates, M.; Tanphaichitr, N. Percoll gradient-centrifuged capacitated mouse sperm have increased fertilizing ability and higher contents of sulfogalactosylglycerolipid and docosahexaenoic acid-containing phosphatidylcholine compared to washed capacitated mouse sperm. Biol. Reprod. 2005, 72, 574-583.
63. Aksoy, Y.; Aksoy, H.; Altinkaynak, K.; Aydin, H.R.; Ozkan, A. Sperm fatty acid composition in inffertile men. Prostag. Leuk. Essent. Fatty 2006, 75, 75-79.
64. Hall, J.C.; Hadley, J.; Doman, T. Correlation between changes in rat sperm membrane lipids, protein, and the membrane physical state during epididymal maturation. J. Androl. 1991, 12, 76-87.
65. Haidl, G.; Opper, C. Changes in lipids and membrane anisotropy in human spermatozoa during epididymal maturation. Hum. Reprod. 1997, 12, 2720-2723.
66. Fischer, K.A.; Van Leyen, K.; Lovercamp, K.W.; Manandhar, G.; Sutovsky, M.; Feng, D.; Safranski, T.; Sutovsky, P. 15-Lipoxygenase is a component of the mammalian sperm cytoplasmic droplet. Reproduction 2005, 130, 213-222.
67. Law, G.L.; McGuinness, M.P.; Linder, C.C.; Griswold, M.D. Expression of apolipoprotein E mRNA in the epithelium and interstitium of the testis and the epididymis. J. Androl. 1997, 18, 32-42.
68. Hermo, L.; Wright, J.; Oko, R.; Morales, C.R. Role of epithelial cells of the male excurrent duct system of the rat in the endocytosis or secretion of sulfated glycoprotein-2 (clusterin). Biol. Reprod. 1991, 44, 1113-1131.
69. Huang, L.S.; Voyiaziakis, E.; Chen, H.L.; Rubin, E.M.; Gordon, J.W. A novel functional role for apolipoprotein B in male infertility in heterozygous apolipoprotein B knockout mice. Proc. Natl. Acad. Sci. USA 1996, 93, 10903-10907.
70. Moghadasian, M.H.; Nguyen, L.B.; Shefer, S.; McManus, B.M.; Frohlich, J.J. Histologic, hematologic, and biochemical characteristics of apo E-deficient mice: effects of dietary cholesterol and phytosterols. Lab. Invest 1999, 79, 355-364.
71. Andersen, O.M.; Yeung, C.H.; Vorum, H.; Wellner, M.; Andreassen, T.K.; Erdmann, B.; Mueller, E.C.; Herz, J.; Otto, A.; Cooper, T.G.; Willnow, T.E. Essential role of the apolipoprotein E receptor-2 in sperm development. J. Biol. Chem. 2003, 278, 23989-23995.
72. Saez, F.; Frenette, G.; Sullivan, R. Epididymosomes and prostasomes: their roles in posttesticular maturation of the sperm cells. J. Androl 2003, 24, 149-154.
73. 2 enzymes in male reproductive organs. Biochim. Biophys. Acta 2004, 1686, 61-76.
74. 2: Isolation of the human gene and cDNAs from porcine pancreas and human lung. DNA 1986, 5, 519-527.
75. 2-mediated lysophospholipid absorption directly contributes to postprandial hyperglycemia. Diabetes 2006, 55, 935-941.
76. 2 inhibitor methyl indoxam suppresses diet-induced obesity and glucose intolerance in mice. Br. J. Pharmacol. 2009, 157, 1263-1269.
77. Wilson, S.G.; Adam, G.; Langdown, M.; Reneland, R.; Braun, A.; Andrew, T.; Surdulescu, G.L.; Norberg, M.; Dudbridge, F.; Reed, P.W.; Sambrook, P.N.; Kleyn, P.W.; Spector, T.D. Linkage and potential association of obesity-related phenotypes with two genes on chromosome 12q24 in a female dizygous twin cohort. Eur. J. Hum Genet 2006, 14, 340-348.
78. 2-A mediator between proximal and distal effectors of inflammation. Immunol. Today 1991, 12, 143-146.
79. 2 with the glycosylphosphatidylinositol-anchored heparan sulfate proteoglycan in the cyclooxygenase-2-mediated delayed prostanoid-biosynthetic pathway. J. Biol. Chem. 1999, 274, 29927-29936.
80. min-induced intestinal neoplasia. Cell 1995, 81, 957-966.
81. Cormier, R.T.; Hong, K.H.; Halberg, R.B.; Hawkins, T.L.; Richardson, P.; Mulherkar, R.; Dove, W.F.; Lander, E.S. Secretory phospholipase Pla2g2a confers resistance to intestinal tumorigenesis. Nat. Genet 1997, 17, 88-91.
82. 2. J. Clin. Invest 1996, 97, 250-257.
83. 2. J. Clin. Invest 1998, 102, 633-638.
84. 2 against Staphylococcus aureus. J. Immunol. 1999, 162, 7402-7408.
85. 2. J. Biol. Chem. 2002, 277, 5849-5857.
86. 2 predict coronary events in patients with coronary artery disease. Circulation 1999, 100, 1280-1284.
87. 2. Arterioscler. Thromb. Vasc. Biol. 1999, 19, 1284-1290.
88. 2 increases atherosclerotic lesion formation in LDL receptor-deficient mice. Arterioscler. Thromb. Vasc. Biol. 2003, 23, 263-268.
89. 2 mRNA to meiotic cells in the mouse. J. Cell Biochem. 1997, 64, 369-375.
90. 2 family, is associated with lymphotoxin deficiency. Genes Immun. 2000, 1, 191-199.
91. 2-IID is an effector molecule of CD4+CD25+ regulatory T cells. Proc. Natl. Acad. Sci. USA 2009, 106, 11673-11678.
92. 2. J. Biol. Chem. 2000, 275, 5785-5793.
93. 2. Cloning, tissue distribution, and functional expression of two novel mouse group II enzymes. J. Biol. Chem. 1999, 274, 31195-31202.
94. 2. J. Biol. Chem. 2002, 277, 19145-19155.
95. 2. J. Biol. Chem. 2000, 275, 39823-39826.
96. 2. Mol. Cell Biol. 2005, 25, 3608-3619.
97. 2 lacking enzymatic activity. Biochemistry 2003, 42, 11494-11503.
98. 2 GXIIB. Hepatology 2011, in press.
99. 2 enzymes. Curr. Opin. Lipidol. 2010, 21, 473-480.
100. Yamamoto, K.; Takemomi, Y.; Miki, Y.; Shimo, K.; Nakanishi, H.; Ikeda, K.; Taguchi, R.; Gelb, M.H.; Murakami, M. The Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan, 2010, unpublished results.